SlideShare a Scribd company logo
1 of 7
Download to read offline
EXECUTIVE SUMMARY
             REPORT #09-002
                                           Capitalizing on New Opportunities




                                                                                                                                                      Overview
                       April 2009

                                           for Stem Cell Products
             Print: $3,200 $2,700
 Electronic (.pdf): $5,200 $4,500



This pre-publication discount price is only available until May 17, 2009!

Overview




                                                                                                                                                   & Key Findings
                                                                                                                                                    Methodology
                                                                       of products purchased from each major supplier), and plan
As a result of the March 9, 2009 reversal of the 2001 restrictions
                                                                       a long-term strategy to secure your leading position in this
on federal funding of human embryonic stem cell research,
                                                                       expanding market. For tactical planning purposes, the report
suppliers of stem cell related products are in need of a fast,
                                                                       includes detailed market share estimates across major stem cell
accurate assessment of new opportunities in the stem cell
                                                                       product categories by market segment, geographic region and top
products market. Additionally, given that practical stem cell-
                                                                       suppliers. Combined with data on scientists’ stem cell research
based therapies can take years to develop, suppliers will benefit
                                                                       budgets and expected changes in spending through 2011,
from a clear understanding of the wide range of products that
                                                                       suppliers can use this information to anticipate areas of growth
support basic stem cell research already in progress. Capitalizing
                                                                       and product saturation.
on New Opportunities for Stem Cell Products, BioInformatics
LLC’s latest report, will enable suppliers to respond quickly to




                                                                                                                                                      Report Highlights
                                                                       One key finding in this report was that only 14% of the scientists
a market disrupted by an Executive Order, and to gain a better
                                                                       surveyed indicated that the lifting of the restrictions on federal
understanding of how today’s stem cell products market is
                                                                       funding for human embryonic stem cell research will affect their
driven by long-term stem cell research requirements.
                                                                                                    decision as to what types of stem cells
                                                                            Contact us at           to use in their research; the majority
In Capitalizing on New Opportunities for Stem Cell Products,
                                                                          703.778.3080 x13 of study will still involve using adult
we surveyed close to 500 scientists from around the world
                                                                                                    stem cells, suggesting that these
about their current—and planned—areas of research, usage of
                                                                        to review the study
                                                                                                    cells will continue to play a major
stem cell products and preferred suppliers. This report will help
                                                                            questionnaire           role in advancing the field of stem
you to determine areas poised for growth (i.e., media, sera,
                                                                                                    cell research. Furthermore, almost
supplements and cell lines) in the stem cell research products
                                                                       half of the scientists indicated that the goal of their research
market, identify potential key competitors (including percentage




                                                                                                                                                      Analyst Expertise
                                                                       is understanding basic biology of stem cells, as opposed to
                                                                       developing cell-based therapies, drug discovery or preclinical/
 Report Objectives                                                     clinical trials. More specifically, we have found that 75% of
                                                                       respondents are focused on stem cell differentiation, which has
                                                                       tremendous implications for product development. (Please see
 • Identify new/expanding stem cell research opportunities             page 2 for supporting data.)
   as a result of the ban on federal funding for research on
   human embryonic stem cells being lifted                             This analysis also provides suppliers with critical insight into
                                                                       optimizing product offerings based upon scientists’ level of
 • Estimate market share and project growth of stem cell
                                                                       satisfaction with stem cell culture products and the level of
   research products by market segment and geographic




                                                                                                                                                      Company Information
                                                                       interest in developing integrated stem cell product lines and
   region
                                                                       services. The scientists surveyed share their opinions on what
 • Estimate market share of top suppliers by stem cell                 new product/technologies would be most beneficial to their
   research product category (i.e., media, sera, supplements,          research. Additionally, the report reveals what channels stem cell
   and cells)                                                          scientists use to access information relevant to their research,
                                                                       which in turn can be used by suppliers to more effectively target
 • Learn types and species of stem cells scientists intend
                                                                       their products and services.
   to use
 • Determine level of satisfaction with stem cell media and            The March 2009 policy change will have implications for life
   unmet needs with respect to stem cell products and cell             science suppliers as academic scientists consider conducting
   lines                                                               research on previously unavailable human embryonic stem cell

                                                                                                            BioInformatics
 • Anticipate change in spending on stem cell products and
                                                                                                                                                      Order Form




   cell lines over the next two to three years (through 2011)                                                  market insights from gene to drug

                                                                                                                        2111 Wilson Blvd
 • Project market size for stem cell products through 2011
                                                                                                                                 Suite 250
 • Uncover interest in integrated stem cell workflow products
                                                                                                                      Arlington, VA 22201
   and services
                                                                                                                     www.gene2drug.com
                                                                                                                        703.778.3081 (fax)
Capitalizing on New Opportunities for Stem Cell Products                                                Executive Summary Page 1 of 7
                                                         ©2009 BioInformatics, LLC
Overview (continued)                                                         Methodology
lines. But while the excitement about human embryonic stem
                                                                              Capitalizing on New Opportunities for Stem Cell
cell research is on the rise, including in the pharmaceutical and
                                                                              Products is based on responses to a 60-question




                                                                                                                                                              Overview
biotech industry, suppliers need actionable information about
                                                                              online survey conducted by BioInformatics, LLC.
scientists’ plans to pursue research using all types of cell lines in
                                                                              The questionnaire was completed by nearly 500 life
a global market. This report provides insights into the origins and
                                                                              scientists worldwide who currently perform stem
sources of stem cells currently used in the lab (adult, embryonic
                                                                              cell research or plan to perform stem cell research
and induced pluripotent) and those likely to be used over the
                                                                              between March 23 and April 6, 2009. The questionnaire
next several years—in addition to differentiated cell types and
                                                                              consisted of 39 closed or partially close-ended
associated diseases under investigation—allowing suppliers to
                                                                              questions and 21 open-ended questions designed to
anticipate the types of stem cell culture products scientists will
                                                                              encourage participation and to meet objectives of the
need to purchase. Moreover, this report includes a supplemental
                                                                              study.
section about scientists who plan to conduct stem cell research




                                                                                                                                                           & Key Findings
                                                                                                                                                            Methodology
in the near future to help companies better anticipate the stem
                                                                              The questions were answered by highly-qualified
cell product needs of new customers.
                                                                              members of The Science Advisory Board™.
                                                                              BioInformatics sponsors The Science Advisory
Capitalizing on New Opportunities for Stem Cell Products
                                                                              Board™, an online community of more than 43,000
provides a roadmap for stem cell product suppliers to help
                                                                              scientists engaged in basic biological research, clinical
navigate a landscape that is poised for change—and growth. This
                                                                              research and drug discovery and development. These
analysis was designed to guide suppliers in redirecting resources
                                                                              experts have agreed to make themselves available
to new areas and markets, and to help refine current offerings
                                                                              to answer questions including emerging areas of
by making them more responsive to scientists who are already
                                                                              research, the tools and techniques used in their labs,
engaged in stem cell research.
                                                                              and their satisfaction with their current suppliers.




                                                                                                                                                              Report Highlights
Key Findings
    Theme That Best Reflects The Goal of Their Research                                       Feature(s) of Stem Cells Studied/Employed

                     Employing stem
                                                                                                                                                    75%
                                                                                      Differentiation
                         cells in
                       preclinical/
                      clinical trials                                                                                            41%
                                                                              Pluripotency marker(s)
                            8%




                                                                                                                                                              Analyst Expertise
                                                                                                                               37%
                                                                                        Self-renewal
 Developing cell-
 based therapies
                                                    Understanding                                                              37%
                                                                                          Propagation
 using stem cells
                                                   the basic biology
       23%
                                                     of stem cells
                                                          45%                                                            30%
                                                                              Drug screening toxicity



                                                                                    Reprogramming                   26%


  Using stem cells
                                                                                                                   23%
                                                                                          Epigenetics
 in drug discovery
       and/or




                                                                                                                                                              Company Information
    development                                                                                          4%
                                                                                               Other
        24%



Is Your Decision as to What Types of Stem Cells to Use Affected by the                                        Embryonic stem cells in
Lifting of the US Restrictions on Federal Funding for Human Embryonic                                         place of adult stem cells
                                                                                                                  and/or induced
Stem Cell Research?
                                                                                                               pluripotent stem cells
   No
                                                                                                              8%
              56%
                                        Yes, because I will                                                                      Embryonic stem cells in
                                                                                                        47%
                              14%          now study...                                                                           addition to adult stem
                                                                                                                 45%               cells and/or induced
                                                                                                                                                              Order Form




                                                                                                                                  pluripotent stem cells
                        13%
              17%                                                      Additional embryonic
                                                                          stem cell lines
                           Don't know/
            Not             not sure
         applicable

Capitalizing on New Opportunities for Stem Cell Products                                                           Executive Summary Page 2 of 7
                                                              ©2009 BioInformatics, LLC
Report Highlights
Capitalizing on New Opportunities for Stem Cell Products
REPORT #09-002




                                                                                                                                            Overview
Section 1. Analysis                                                       • Source and type of stem cell lines plan to use two to
                                                                            three years from now (2010 and 2011)
Market Size and Share and Market Growth Potential
                                                                          • Impact on research of lifting US restrictions on federal
  • Estimated market share for stem cell research products
                                                                            funding of embryonic stem cells
    by market segment and geographic region
                                                                          • Differentiated cell types that were/are/will be the focus
  • Estimated market share of top suppliers by stem
                                                                            of stem cell research for 2008, 2009, and two to three
    cell research product category (i.e., media, sera,
                                                                            years from now (2010 and 2011)
    supplements, and cells)




                                                                                                                                         & Key Findings
                                                                                                                                          Methodology
                                                                          • Diseases that are the focus of stem cell research by type
  • Projected growth of stem cell research products market
                                                                            of stem cell
    by market segment and geographic region
                                                                          • Top scientific journals respondents rate as most critical
  • Anticipated stem cell research budgets for 2009 by
                                                                            to their stem cell research
    market segment and geographic region
                                                                          • Critical stem cell conferences
  • Expected change in spending on stem cell products
    and cell lines over the next two to three years (through
    2011)                                                              Stem Cell Culture Products: Top Suppliers and Budgets
                                                                          • Suppliers from whom respondents purchase stem cell
                                                                            culture products




                                                                                                                                            Report Highlights
Frequently Asked Questions (related to):
                                                                          • Percent of stem cell culture product purchases made
  • Products needed to support scientists’ current stem cell
                                                                            from leading suppliers
    research
                                                                          • Estimated 2008 budget for stem cell culture products
  • Cell types and disease that are/will be the focus of stem
    cell research                                                         • Percent of 2008 budget spent on stem cell media, sera,
                                                                            and supplements
  • Use of embryonic versus induced pluripotent cells for
    specific applications                                                 • Estimated 2009 budget that will be dedicated to stem cell
                                                                            culture products and stem cell lines
  • Unmet product needs and product differentiation
    strategies                                                            • Percent of 2009 budget that will be spent on stem cell




                                                                                                                                            Analyst Expertise
                                                                            media, sera, and supplements
  • New product and/or service development opportunities
                                                                          • Expected change in expenditures on stem cell media,
  • Best channels by which to communicate with and
                                                                            sera, and supplements over the next two to three years
    market to stem cell researchers
                                                                            (2010 and 2011)


                                                                       Stem Cell Media: Usage, Product Features and Special
Section 2. Methodology & Demographics                                  Requirements
  • Objectives                                                            • Types of media used to grow and culture stem cells
  • Questionnaire design                                                  • Percent of media that is custom vs. off-the-shelf




                                                                                                                                            Company Information
  • Survey population                                                     • Estimate of stem cell culture media used per month in
                                                                            2008
                                                                          • Estimate of stem cell culture media expected to be used
                                                                            per month in 2009
Section 3. Presentation of the Survey Data:
                                                                          • Expected change in stem cell culture media usage for
Respondents Conducting Stem Cell Research                                   two to three years from now (2010 and 2011)
Research Overview and Applications
                                                                          • Importance of xeno-free and animal-free types of stem
  • Length of time conducting research                                      cell culture media
  • Goals of stem cell research                                           • Advantages of stem cell culture media from primary
                                                                            supplier
  • Features of stem cells studied
                                                                                                                                            Order Form




                                                                          • Satisfaction with features of stem cell culture media from
  • Source, type, and number of different stem cell lines
                                                                            primary supplier
    used in 2008
                                                                          • Requirements for GMP conditions for stem cell culture
  • Source, type, and number of different stem cell lines
                                                                            products
    expected to be used in 2009


Capitalizing on New Opportunities for Stem Cell Products                                              Executive Summary Page 3 of 7
                                                         ©2009 BioInformatics, LLC
Report Highlights (continued)
Capitalizing on New Opportunities for Stem Cell Products
REPORT #09-002




                                                                                                                                        Overview
Stem Cells: Sources, Budgets, and Special Requirements               Additional Analysis by:
                                                                                                                     hoose
                                                                                                               Why C port?
  • General sources from which respondents acquire                      • Market segment
                                                                                                                      e
                                                                                                               This R
    stem cells                                                          • Geographic region
                                                                                                                         )     5
                                                                                                                         age
  • Percent of stem cell purchases made from major sources
                                                                                                                  (see p
                                                                        • Years of experience
    in 2008
                                                                        • Stem cell type
  • Percent of stem cell purchases expected to be made from
                                                                        • Research focus
    major sources in 2009




                                                                                                                                     & Key Findings
                                                                                                                                      Methodology
                                                                        • Lab size
  • Expected changes in the percent of stem cell purchases
    expected to be made from commercial suppliers over the
    next two to three years (2010 and 2011)
  • Commercial suppliers and/or national bank/repositories
                                                                     Section 4. Appendices
    from which respondents currently purchase stem cells
                                                                     Appendix A. Respondents Planning to Conduct Stem Cell
  • Percent of stem cell purchases made from commercial
                                                                     Research
    suppliers and/or national bank/repositories
                                                                        • Time frame that respondents plan to begin stem cell
  • Estimated 2008 budget for stem cell lines
                                                                          research
  • Estimated 2009 budget that will be dedicated to stem cell




                                                                                                                                        Report Highlights
                                                                        • Sources of funding that will support future stem cell
    lines
                                                                          research
  • Reasons why respondents acquire stem cells from their
                                                                        • Anticipated annual budget for stem cell culture products
    primary suppliers
                                                                          and stem cell lines
  • Percent of stem cells grown on feeders and sources of
                                                                        • Sources and types of stem cells respondents plan to use
    feeder cells
                                                                          in their research
  • Use of 3-D cell culture in stem cell research
                                                                        • Differentiated cell types that will be the focus of stem
  • Reasons for interest in 3-D cell culture for stem cell                cell research
    research
                                                                        • Diseases that will be the focus of stem cell research by




                                                                                                                                        Analyst Expertise
                                                                          cell type
Supporting Products, Technologies, and Services                         • Sources from which respondents plan to acquire
                                                                          stem cells
  • Techniques respondents use to identify differentiated cell
    types derived from stem cells
  • Major disadvantages of techniques used to identify               Appendix B. Verbatim Responses to Questions
    differentiated cell types derived from stem cells
                                                                        • Do you think your stem cell research will change due
  • Primary supplier of consumable products used to                       to the lifting of US restrictions on federal funding
    perform techniques for identifying differentiated cell                for human embryonic stem cell research by the new
    types derived from stem cells                                         presidential administration? Why or why not?




                                                                                                                                        Company Information
  • Stem cell-specific kits or panels currently used and                • Like many stem cell pioneers, Ian Wilmut, the creator of
    planned to use in the next 12 months                                  Dolly the sheep, has embraced an alternative approach.
                                                                          Are induced pluripotent stem cells the beginning of the
  • Stages of stem cell workflow processes with which
                                                                          end for embryonic cloning? Why or why not?
    respondents are involved
  • Stage of stem cell workflow that respondents would
    most like a new product/technology to facilitate their
    research
  • Types of stem cell-related services that respondents
    would be most interested in obtaining from suppliers
  .
                                                                                                                                        Order Form




Capitalizing on New Opportunities for Stem Cell Products                                            Executive Summary Page 4 of 7
                                                       ©2009 BioInformatics, LLC
Other Recent Publications*
Life Science Marketing




                                                                                                                                              Overview
#09-001     Prospering in a Down Market: Strategies for Life Science Suppliers                                March 2009      159 Pages
#08-047     The Brave New World of Scientific Publishing                                                  November 2008       154 Pages
#08-019     Enabling Discovery: The 2008 Life Science Industry Awards                                          June 2008       101 Pages
                                                                          TM


#08-008     Instrumentation Service Contracts: Opportunities for Differentiation                                July 2008     136 Pages
#08-007     Protein Research: Strategies for Marketing to Chemists and Biologists                         September 2008      123 Pages
#08-006     Understanding Switching Dynamics: Maximizing Customer Retention in the Life Science               March 2008      173 Pages
#08-004     Life Science Product Catalogs: Techniques to Increase Sales                                       March 2008       92 Pages




                                                                                                                                           & Key Findings
                                                                                                                                            Methodology
#08-003     Conference & Exhibit Strategies in the Life Sciences: What’s Working Now                       February 2008      135 Pages
#08-002     Advertising to Life Scientists: Resolving the Print vs. Online Dilemma                         February 2008       105 Pages
#08-001     Marketing to Life Scientists: Capturing Customers’ Attention in Applied Markets                 January 2008      156 Pages

                                                                                * See Web site www.gene2drug.com for a complete listing.




 With hundreds of stem cell products market reports
 to choose from, why choose ours?




                                                                                                                                              Report Highlights
The design and analysis of Capitalizing on                             Carefully Selected Survey Participants
New Opportunities for Stem Cell Products                               When others promote results from their online surveys,
                                                                       they fail to mention the uncontrolled nature of their
was spearheaded by BioInformatics LLC’s Vice
                                                                       broadcast email invitations. To provide you with the most
President of Advisory Services Tamara Zemlo,
                                                                       valid and accurate results possible, the respondents to our
Ph.D., MPH, who has been the lead analyst on
                                                                       surveys are members of our unique online panel—The
over 80 syndicated market research reports. For
                                                                       Science Advisory Board—which consists of more than
this study, Dr. Zemlo consulted with multiple                          43,000 verified life science and biomedical professionals
stem cell products vendors to optimize the




                                                                                                                                              Analyst Expertise
                                                                       who have agreed to take part in our surveys, focus groups
relevance of this study with regards to the                            and other market research activities. These respondents
current stem cell research market.                                     are carefully selected based on their professional
                                                                       qualifications, market segments and geographic
                                                                       regions—we can even select them based on the products
Sources of Independent, Unbiased Research
                                                                       they use and their preferred suppliers.
Unlike reports from other firms that are based on an
analyst’s subjective summary of information from publicly
available sources, our reports are based on the results
                                                                        Don’t settle for an imitation. Invest in the most
of detailed surveys of hundreds—even thousands—of
                                                                        direct source of information from the scientists
scientific and medical professionals who buy your




                                                                                                                                              Company Information
                                                                        who buy your products, and the expert team that
products.
                                                                        has been monitoring your clients since 1994.
Developed by a Team of Experts
                                                                       Complimentary Consulting Provided
Our questionnaires are developed by a multi-
disciplinary team of scientists, industry veterans and                 With your purchase, we offer one free hour of consultation
market research experts with years of experience. These                with our talented team of scientific and business analysts
professionals understand that survey questions need to                 who created the report. During this consultation, we can
be asked in a way that ensures the answers will directly               answer any questions you may have about the survey
address the business challenges you face. Once the survey              results and what we believe to be the significant trends
data is collected, this same team creates a unique report              affecting the market.
that presents the reader with a thorough understanding of
                                                                       Custom Analysis & Research Available
the topic and the scientific and business implications of
                                                                                                                                              Order Form




the results based on sophisticated statistical analytics.              If you’d like to delve deeper into the data from a study,
                                                                       we can always perform custom cross-tabulations or other
                                                                       analysis on your behalf. We can even pose follow-up
                                                                       questions to respondents who answered in a particular
                                                                       way or conduct a custom study to extend your knowledge.


Capitalizing on New Opportunities for Stem Cell Products                                                Executive Summary Page 5 of 7
                                                           ©2009 BioInformatics, LLC
About BioInformatics, LLC                                                    Our strength lies in our ability to integrate our understanding of
                                                                             science and medicine with cutting-edge market research techniques.
                                                                             As one of the first firms to recognize how the World Wide Web has
Since our inception in 1994, BioInformatics has provided critical
                                                                             transformed market research, BioInformatics formed The Science
market intelligence to leading companies serving the life science,
medical device and pharmaceutical industries. We support clients             Advisory Board. Launched in 1997, this global community currently




                                                                                                                                                            Overview
across the entire market spectrum—from scientific research to                consists of more than 43,000 life science researchers, physicians
diagnostics and therapeutics—providing high-level management with            and biomedical professionals who convene regularly via the Web to
market insights from gene to drug.                                           voice their opinions on a wide variety of issues relating to biomedical
                                                                             research and clinical technologies. Clients tap into this panel of
Our multi-disciplinary team of scientific experts and business               experts and receive answers to their critical marketing questions in
analysts creates value for our clients by combining extensive industry       days, rather than weeks. In addition to providing real-time insights
knowledge and experience. We offer a variety of products and                 into the perceptions of the market, posing questions to The Science
services that enable executives to see themselves, their market and
                                                                             Advisory Board offers substantial cost savings over gathering
their competitors through the eyes of the most important information
                                                                             information via traditional market research techniques.
source of all—customers. We can precisely meet the needs of our




                                                                                                                                                         & Key Findings
                                                                                                                                                          Methodology
clients through the most appropriate mix of research methodologies,
                                                                             BioInformatics offers both published reports and custom research
including:
                                                                             services. Published reports allow marketing professionals to share in
           • Online Surveys
                                                                             the results of broad-based market studies that provide access to high
           • Online Focus Groups
                                                                             quality research at an affordable price. Our custom research is tailored
           • Mail Surveys
                                                                             to the specific needs of the company’s executive management. For
           • Telephone Interviews
                                                                             more information about BioInformatics’ product and service offerings,
                                                                             please visit our Web site at www.gene2drug.com, call 703.778.3080 or
                                                                             email info@gene2drug.com.


Our Valued Clients




                                                                                                                                                            Report Highlights
Biotechnology/Life Science   Eppendorf                     Plexagen Diagnostics           Ortho-Clinical Diagnostics     Phillip Johnson & Associates
454                          Eurogentec                    Post Genome Institute          Radiometer America             PA Consulting
AbCam                        Expression Pathology          Promega                        Tektronix                      Perry Ballard
Accelrys                     Fermentas                     Protein Forest                                                Piper Jaffray
                                                                                          Pharmaceuticals
Affymetrix                   Fluidigm                      Proteome Systems                                              Ruder Finn
Agencourt Bioscience         GE Healthcare                 Qbiogene                       Abbott Laboratories            Scherago International
Agilent Technologies         Gen-Probe                     QIAGEN                         Amgen                          Select Equity Group
American Type Culture        Gene Codes                    R & D Systems                  AstraZeneca                    Stephan & Brady
  Collection                 Gene Logic                    Ribomed Biotechnologies        Aventis                        The Strategy Works
Anachem                      Gene Therapy Systems          Rosetta Biosoftware            Baxter Healthcare              UBS Warburg
Antibodies By Design         Gentra Systems                Sachem                         Bayer
Apple Computer                                                                                                           Publishers & Associations
                             GenVault Corporation          Sarstedt                       Boehringer Ingelheim
Applied Biosystems                                                                           Pharmaceuticals
                             Genzyme                       Sandia National Laboratories                                  Academic Press




                                                                                                                                                            Analyst Expertise
Applied Precision                                                                         Cardinal Health
                             Guava Technologies            SAS Institute                                                 American Academy of
Axxora                                                                                    Centocor                         Pediatrics
                             Helicos BioSciences           Schott Nexterion
BD Biosciences                                                                            Hoechst Marion Roussel         AAAS/Science
                             Hewlett-Packard               Sequenom
Beckman Coulter                                                                           ICN Pharmaceuticals            American Medical Association
                             High Throughput Genomics      Serologicals
Biacore                                                                                   Janssen Pharmaceutica          American Society for Cell
                             Hitachi Instruments           Serotec
                                                                                                                           Biology
Bio-Rad Laboratories                                                                      Merck
                             Hybrigenics                   Sigma-Aldrich
                                                                                                                         American Society for
Bioneer                                                                                   Novartis Pharmaceuticals
                             Hyseq                         Solexa
                                                                                                                           Microbiology
Biotage                                                                                   Novo Nordisk
                             IBM Life Sciences             SomaLogic
                                                                                                                         American Society of Human
                                                                                             Pharmaceuticals
BioTrove                     Illumina                      Source Precision Medicine
                                                                                                                           Genetics
                                                                                          Pfizer
Blue Heron Biotechnology     Immunotech                    Stratagene
                                                                                                                         BioTechniques/Eaton
                                                                                          Schering-Plough
Caliper Technologies         InforMax                      Stressgen Biotechnologies
                                                                                                                           Publishing
Callida Genomics             Integrated DNA Technologies   Takara Mirus Bio
                                                                                                                         Blackwell Publishing




                                                                                                                                                            Company Information
                                                                                          Professional Services
Cambrex Bio Science          Invitrogen                    Tecan
                                                                                                                         Cold Spring Harbor
                                                                                          & Finance
Carl Zeiss                   JRH Biosciences               The Jackson Laboratory
                                                                                                                           Laboratory Press
                                                                                          Adjuvant Partners
Cell Signaling Technology    Kirkegaard & Perry            Thermo Fisher Scientific
                                                                                                                         Elsevier
                                                                                          Adventus Research
Celliance                       Laboratories               Thomas Scientific
                                                                                                                         Federation of Amer. Societies
                                                                                          Agency.com
Charles River Laboratories   Kodak Scientific Imaging      Tocris Cookson
                                                                                                                           for Experimental Biology
                                                                                          Anvil Group
ChromaVision Medical         Leica Microsystems            Transgenomic
                                                                                                                         Harvard University Medical
                                                                                          Atlas Venture
  Systems                    LI-COR                        UVP
                                                                                                                           School
                                                                                          Battelle Memorial Institute
Cipher Systems               LION bioscience               Varian
                                                                                                                         John Wiley & Sons
                                                                                          BioOnline
Clontech Laboratories        Lonza                         VWR International
                                                                                                                         Mary Ann Liebert Publishers
                                                                                          Citadel Investment Group
Corning                      Luminex                       Vysis
                                                                                                                         Nature Publishing Group
                                                                                          Doran Media Services
DAKO                         MDS Sciex                     Waters
                                                                                                                         New England Journal of
                                                                                          Fidelity Management and
DNAStar                      Mettler-Toledo AutoChem       Whatman
                                                                                                                           Medicine
                                                                                             Research
Dow Corning                  Millipore
                                                                                                                         Society for Neuroscience
                                                                                          Foley & Lardner
Dynal Biotech                MiraiBio                      Medical Diagnostics
                                                                                                                         Springer-Verlag
                                                                                          Gerson Lehrman Group
eBIOINFORMATICS              Molecular Devices             Applied Imaging
                                                                                                                         Stanford University High Wire
                                                                                          HSBC Securities
Edge Biosystems              MWG Biotech                   Ciba Corning Diagnostics
                                                                                                                                                            Order Form




                                                                                                                           Press
                                                                                          Infotrieve
Eksigent Technologies        New England Biolabs           Dade Behring
                                                                                                                         Thomson ISI
                                                                                          Innovative Marketing Group
EM Separations Technology    NuGEN Technologies            Diagnostic Products
                                                                                                                         Wolters Kluwer
                                                                                          McKinsey & Co.
EMD Biosciences              Ovid Technologies             Diametrics Medical
                                                                                          Nathan Associates
Entelechon                   Pall Life Sciences            Hewlett-Packard Medical
                                                                                          National Research Council of
Epigenomics                  Percival Scientific              Products
                                                                                             Canada
Epitomics                    PerkinElmer Life Sciences     LifeScan
                                                                                          Novintel
Epoch Biosciences            Photometrics                  Mallinckrodt


Capitalizing on New Opportunities for Stem Cell Products                                                        Executive Summary Page 6 of 7
                                                             ©2009 BioInformatics, LLC
BioInformatics
REPORT #09-002                                                                                                              market insights from gene to drug

Capitalizing on New Opportunities for Stem Cell Products




                                                                                                                                                                          Overview
PRE-PUBLICATION DISCOUNT PRICES are only available until May 17, 2009!
        Print Copy—$3,200 Now $2,700!
        Electronic Copy (includes one print copy)—$5,200 Now $4,500!



 Ordering Information                                                                 Electronic Copy
 To place an order, fill out this form and mail it to BioInformatics, LLC or fax      This format allows an unlimited number of users within your company
 it to 703.778.3081. Alternatively, you may submit your order by emailing             to access the report regardless of geographic location. You may place the
 sales@gene2drug.com, calling 703.778.3080 or visiting                                electronic copy (PDF) on your secure, corporate intranet or share it with




                                                                                                                                                                       & Key Findings
                                                                                                                                                                        Methodology
 www.gene2drug.com/order/201/.                                                        co-workers via email. In addition to providing greater accessibility, the
                                                                                      electronic copy allows you to easily navigate the document with the help
 Payment must be made within 30 days and in U.S. dollars.                             of bookmarks, quickly search key words or phrases and print out any page.
 BioInformatics’ Federal Tax ID #: 54-2001907.                                        One print copy of the report is also provided at no additional cost.

 Credit Card                                                                          Data Set
 You may charge your order to American Express, MasterCard, Visa,                     To accommodate your unique needs, the raw data is also available. With
 Diner’s Card or Discover. Please include your credit card account number,            the data, you can analyze respondents’ answer choices in any way needed,
 expiration date and signature.                                                       including cross-tabulations, correlations, etc. The data set is offered in two
                                                                                      formats: SPSS® Base or Microsoft® Excel, and may only be purchased in
 Wire Transfers                                                                       conjunction with the company-wide electronic copy of the report.
 Wire transfers should be sent to: SunTrust Bank, 2121 15th Street, Arlington,




                                                                                                                                                                          Report Highlights
 VA 22201, SWIFT #SNTRUS3A, ABA #071000104, Account #702260169.



I wish to order the following format of REPORT #09-002,
Capitalizing on New Opportunities for Stem Cell Products
                                                                                                                             Discount Price
o Print Copy                                                                                                                     $2,700               $________

o Electronic Copy (.pdf, includes print copy)                                                                                    $4,500               $________

o Add Data Set                Excel or SPSS (circle one)                                                                      +$1,200               +$________
Additional print copies                                                                                            _____ x $300 each	               +$________




                                                                                                                                                                          Analyst Expertise
                                                                                       Promo Code ___________                                       –$________
                                                                                          Shipping & Handling
                                                                                                                                                    +$________
                                                                                    (Add $15 for U.S., $50 for Int’l)
                                                                                                                                                     $________
                                                                                                                                          Total



                                                                                     o Check Enclosed (Payable to BioInformatics, LLC)




                                                                                                                                                                          Company Information
                                                                                     o Purchase Order # ________________________________________
Name
                                                                                     o Bill Me
Title

                                                                                     o Am Ex o MasterCard o Visa o Diner’s Card o Discover
Organization

                                                                                      /
Street Address                                                                       Credit Card #                                                   Exp Date
                                                                                                                                                     (MM/YY)
City, State/Province, Postal Code                                                    Name on card _____________________________________________

Country
                                                                                     Order Authorized By:
                                                                                                                                                                          Order Form




Phone                                     Fax
                                                                                     __________________________________________________________
                                                                                       Signature                                             Date
Email

                                                       BioInformatics, LLC
                                        2111 Wilson Blvd., Suite 250 Arlington, VA 22201
               Web: www.gene2drug.com • Phone: 703.778.3080 x13 • Fax: 703.778.3081 • Email: m.follin@gene2drug.com

Capitalizing on New Opportunities for Stem Cell Products                                                                     Executive Summary Page 7 of 7
                                                                       ©2009 BioInformatics, LLC

More Related Content

Recently uploaded

Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 

Recently uploaded (20)

Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 

Featured

PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)contently
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024Albert Qian
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsKurio // The Social Media Age(ncy)
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Search Engine Journal
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summarySpeakerHub
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next Tessa Mero
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentLily Ray
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best PracticesVit Horky
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project managementMindGenius
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...RachelPearson36
 
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Applitools
 
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at WorkGetSmarter
 
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...DevGAMM Conference
 

Featured (20)

Skeleton Culture Code
Skeleton Culture CodeSkeleton Culture Code
Skeleton Culture Code
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
 
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work
 
ChatGPT webinar slides
ChatGPT webinar slidesChatGPT webinar slides
ChatGPT webinar slides
 
More than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike RoutesMore than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike Routes
 
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
 

Capitalizing on New Opportunities for Stem Cell Products

  • 1. EXECUTIVE SUMMARY REPORT #09-002 Capitalizing on New Opportunities Overview April 2009 for Stem Cell Products Print: $3,200 $2,700 Electronic (.pdf): $5,200 $4,500 This pre-publication discount price is only available until May 17, 2009! Overview & Key Findings Methodology of products purchased from each major supplier), and plan As a result of the March 9, 2009 reversal of the 2001 restrictions a long-term strategy to secure your leading position in this on federal funding of human embryonic stem cell research, expanding market. For tactical planning purposes, the report suppliers of stem cell related products are in need of a fast, includes detailed market share estimates across major stem cell accurate assessment of new opportunities in the stem cell product categories by market segment, geographic region and top products market. Additionally, given that practical stem cell- suppliers. Combined with data on scientists’ stem cell research based therapies can take years to develop, suppliers will benefit budgets and expected changes in spending through 2011, from a clear understanding of the wide range of products that suppliers can use this information to anticipate areas of growth support basic stem cell research already in progress. Capitalizing and product saturation. on New Opportunities for Stem Cell Products, BioInformatics LLC’s latest report, will enable suppliers to respond quickly to Report Highlights One key finding in this report was that only 14% of the scientists a market disrupted by an Executive Order, and to gain a better surveyed indicated that the lifting of the restrictions on federal understanding of how today’s stem cell products market is funding for human embryonic stem cell research will affect their driven by long-term stem cell research requirements. decision as to what types of stem cells Contact us at to use in their research; the majority In Capitalizing on New Opportunities for Stem Cell Products, 703.778.3080 x13 of study will still involve using adult we surveyed close to 500 scientists from around the world stem cells, suggesting that these about their current—and planned—areas of research, usage of to review the study cells will continue to play a major stem cell products and preferred suppliers. This report will help questionnaire role in advancing the field of stem you to determine areas poised for growth (i.e., media, sera, cell research. Furthermore, almost supplements and cell lines) in the stem cell research products half of the scientists indicated that the goal of their research market, identify potential key competitors (including percentage Analyst Expertise is understanding basic biology of stem cells, as opposed to developing cell-based therapies, drug discovery or preclinical/ Report Objectives clinical trials. More specifically, we have found that 75% of respondents are focused on stem cell differentiation, which has tremendous implications for product development. (Please see • Identify new/expanding stem cell research opportunities page 2 for supporting data.) as a result of the ban on federal funding for research on human embryonic stem cells being lifted This analysis also provides suppliers with critical insight into optimizing product offerings based upon scientists’ level of • Estimate market share and project growth of stem cell satisfaction with stem cell culture products and the level of research products by market segment and geographic Company Information interest in developing integrated stem cell product lines and region services. The scientists surveyed share their opinions on what • Estimate market share of top suppliers by stem cell new product/technologies would be most beneficial to their research product category (i.e., media, sera, supplements, research. Additionally, the report reveals what channels stem cell and cells) scientists use to access information relevant to their research, which in turn can be used by suppliers to more effectively target • Learn types and species of stem cells scientists intend their products and services. to use • Determine level of satisfaction with stem cell media and The March 2009 policy change will have implications for life unmet needs with respect to stem cell products and cell science suppliers as academic scientists consider conducting lines research on previously unavailable human embryonic stem cell BioInformatics • Anticipate change in spending on stem cell products and Order Form cell lines over the next two to three years (through 2011) market insights from gene to drug 2111 Wilson Blvd • Project market size for stem cell products through 2011 Suite 250 • Uncover interest in integrated stem cell workflow products Arlington, VA 22201 and services www.gene2drug.com 703.778.3081 (fax) Capitalizing on New Opportunities for Stem Cell Products Executive Summary Page 1 of 7 ©2009 BioInformatics, LLC
  • 2. Overview (continued) Methodology lines. But while the excitement about human embryonic stem Capitalizing on New Opportunities for Stem Cell cell research is on the rise, including in the pharmaceutical and Products is based on responses to a 60-question Overview biotech industry, suppliers need actionable information about online survey conducted by BioInformatics, LLC. scientists’ plans to pursue research using all types of cell lines in The questionnaire was completed by nearly 500 life a global market. This report provides insights into the origins and scientists worldwide who currently perform stem sources of stem cells currently used in the lab (adult, embryonic cell research or plan to perform stem cell research and induced pluripotent) and those likely to be used over the between March 23 and April 6, 2009. The questionnaire next several years—in addition to differentiated cell types and consisted of 39 closed or partially close-ended associated diseases under investigation—allowing suppliers to questions and 21 open-ended questions designed to anticipate the types of stem cell culture products scientists will encourage participation and to meet objectives of the need to purchase. Moreover, this report includes a supplemental study. section about scientists who plan to conduct stem cell research & Key Findings Methodology in the near future to help companies better anticipate the stem The questions were answered by highly-qualified cell product needs of new customers. members of The Science Advisory Board™. BioInformatics sponsors The Science Advisory Capitalizing on New Opportunities for Stem Cell Products Board™, an online community of more than 43,000 provides a roadmap for stem cell product suppliers to help scientists engaged in basic biological research, clinical navigate a landscape that is poised for change—and growth. This research and drug discovery and development. These analysis was designed to guide suppliers in redirecting resources experts have agreed to make themselves available to new areas and markets, and to help refine current offerings to answer questions including emerging areas of by making them more responsive to scientists who are already research, the tools and techniques used in their labs, engaged in stem cell research. and their satisfaction with their current suppliers. Report Highlights Key Findings Theme That Best Reflects The Goal of Their Research Feature(s) of Stem Cells Studied/Employed Employing stem 75% Differentiation cells in preclinical/ clinical trials 41% Pluripotency marker(s) 8% Analyst Expertise 37% Self-renewal Developing cell- based therapies Understanding 37% Propagation using stem cells the basic biology 23% of stem cells 45% 30% Drug screening toxicity Reprogramming 26% Using stem cells 23% Epigenetics in drug discovery and/or Company Information development 4% Other 24% Is Your Decision as to What Types of Stem Cells to Use Affected by the Embryonic stem cells in Lifting of the US Restrictions on Federal Funding for Human Embryonic place of adult stem cells and/or induced Stem Cell Research? pluripotent stem cells No 8% 56% Yes, because I will Embryonic stem cells in 47% 14% now study... addition to adult stem 45% cells and/or induced Order Form pluripotent stem cells 13% 17% Additional embryonic stem cell lines Don't know/ Not not sure applicable Capitalizing on New Opportunities for Stem Cell Products Executive Summary Page 2 of 7 ©2009 BioInformatics, LLC
  • 3. Report Highlights Capitalizing on New Opportunities for Stem Cell Products REPORT #09-002 Overview Section 1. Analysis • Source and type of stem cell lines plan to use two to three years from now (2010 and 2011) Market Size and Share and Market Growth Potential • Impact on research of lifting US restrictions on federal • Estimated market share for stem cell research products funding of embryonic stem cells by market segment and geographic region • Differentiated cell types that were/are/will be the focus • Estimated market share of top suppliers by stem of stem cell research for 2008, 2009, and two to three cell research product category (i.e., media, sera, years from now (2010 and 2011) supplements, and cells) & Key Findings Methodology • Diseases that are the focus of stem cell research by type • Projected growth of stem cell research products market of stem cell by market segment and geographic region • Top scientific journals respondents rate as most critical • Anticipated stem cell research budgets for 2009 by to their stem cell research market segment and geographic region • Critical stem cell conferences • Expected change in spending on stem cell products and cell lines over the next two to three years (through 2011) Stem Cell Culture Products: Top Suppliers and Budgets • Suppliers from whom respondents purchase stem cell culture products Report Highlights Frequently Asked Questions (related to): • Percent of stem cell culture product purchases made • Products needed to support scientists’ current stem cell from leading suppliers research • Estimated 2008 budget for stem cell culture products • Cell types and disease that are/will be the focus of stem cell research • Percent of 2008 budget spent on stem cell media, sera, and supplements • Use of embryonic versus induced pluripotent cells for specific applications • Estimated 2009 budget that will be dedicated to stem cell culture products and stem cell lines • Unmet product needs and product differentiation strategies • Percent of 2009 budget that will be spent on stem cell Analyst Expertise media, sera, and supplements • New product and/or service development opportunities • Expected change in expenditures on stem cell media, • Best channels by which to communicate with and sera, and supplements over the next two to three years market to stem cell researchers (2010 and 2011) Stem Cell Media: Usage, Product Features and Special Section 2. Methodology & Demographics Requirements • Objectives • Types of media used to grow and culture stem cells • Questionnaire design • Percent of media that is custom vs. off-the-shelf Company Information • Survey population • Estimate of stem cell culture media used per month in 2008 • Estimate of stem cell culture media expected to be used per month in 2009 Section 3. Presentation of the Survey Data: • Expected change in stem cell culture media usage for Respondents Conducting Stem Cell Research two to three years from now (2010 and 2011) Research Overview and Applications • Importance of xeno-free and animal-free types of stem • Length of time conducting research cell culture media • Goals of stem cell research • Advantages of stem cell culture media from primary supplier • Features of stem cells studied Order Form • Satisfaction with features of stem cell culture media from • Source, type, and number of different stem cell lines primary supplier used in 2008 • Requirements for GMP conditions for stem cell culture • Source, type, and number of different stem cell lines products expected to be used in 2009 Capitalizing on New Opportunities for Stem Cell Products Executive Summary Page 3 of 7 ©2009 BioInformatics, LLC
  • 4. Report Highlights (continued) Capitalizing on New Opportunities for Stem Cell Products REPORT #09-002 Overview Stem Cells: Sources, Budgets, and Special Requirements Additional Analysis by: hoose Why C port? • General sources from which respondents acquire • Market segment e This R stem cells • Geographic region ) 5 age • Percent of stem cell purchases made from major sources (see p • Years of experience in 2008 • Stem cell type • Percent of stem cell purchases expected to be made from • Research focus major sources in 2009 & Key Findings Methodology • Lab size • Expected changes in the percent of stem cell purchases expected to be made from commercial suppliers over the next two to three years (2010 and 2011) • Commercial suppliers and/or national bank/repositories Section 4. Appendices from which respondents currently purchase stem cells Appendix A. Respondents Planning to Conduct Stem Cell • Percent of stem cell purchases made from commercial Research suppliers and/or national bank/repositories • Time frame that respondents plan to begin stem cell • Estimated 2008 budget for stem cell lines research • Estimated 2009 budget that will be dedicated to stem cell Report Highlights • Sources of funding that will support future stem cell lines research • Reasons why respondents acquire stem cells from their • Anticipated annual budget for stem cell culture products primary suppliers and stem cell lines • Percent of stem cells grown on feeders and sources of • Sources and types of stem cells respondents plan to use feeder cells in their research • Use of 3-D cell culture in stem cell research • Differentiated cell types that will be the focus of stem • Reasons for interest in 3-D cell culture for stem cell cell research research • Diseases that will be the focus of stem cell research by Analyst Expertise cell type Supporting Products, Technologies, and Services • Sources from which respondents plan to acquire stem cells • Techniques respondents use to identify differentiated cell types derived from stem cells • Major disadvantages of techniques used to identify Appendix B. Verbatim Responses to Questions differentiated cell types derived from stem cells • Do you think your stem cell research will change due • Primary supplier of consumable products used to to the lifting of US restrictions on federal funding perform techniques for identifying differentiated cell for human embryonic stem cell research by the new types derived from stem cells presidential administration? Why or why not? Company Information • Stem cell-specific kits or panels currently used and • Like many stem cell pioneers, Ian Wilmut, the creator of planned to use in the next 12 months Dolly the sheep, has embraced an alternative approach. Are induced pluripotent stem cells the beginning of the • Stages of stem cell workflow processes with which end for embryonic cloning? Why or why not? respondents are involved • Stage of stem cell workflow that respondents would most like a new product/technology to facilitate their research • Types of stem cell-related services that respondents would be most interested in obtaining from suppliers . Order Form Capitalizing on New Opportunities for Stem Cell Products Executive Summary Page 4 of 7 ©2009 BioInformatics, LLC
  • 5. Other Recent Publications* Life Science Marketing Overview #09-001 Prospering in a Down Market: Strategies for Life Science Suppliers March 2009 159 Pages #08-047 The Brave New World of Scientific Publishing November 2008 154 Pages #08-019 Enabling Discovery: The 2008 Life Science Industry Awards June 2008 101 Pages TM #08-008 Instrumentation Service Contracts: Opportunities for Differentiation July 2008 136 Pages #08-007 Protein Research: Strategies for Marketing to Chemists and Biologists September 2008 123 Pages #08-006 Understanding Switching Dynamics: Maximizing Customer Retention in the Life Science March 2008 173 Pages #08-004 Life Science Product Catalogs: Techniques to Increase Sales March 2008 92 Pages & Key Findings Methodology #08-003 Conference & Exhibit Strategies in the Life Sciences: What’s Working Now February 2008 135 Pages #08-002 Advertising to Life Scientists: Resolving the Print vs. Online Dilemma February 2008 105 Pages #08-001 Marketing to Life Scientists: Capturing Customers’ Attention in Applied Markets January 2008 156 Pages * See Web site www.gene2drug.com for a complete listing. With hundreds of stem cell products market reports to choose from, why choose ours? Report Highlights The design and analysis of Capitalizing on Carefully Selected Survey Participants New Opportunities for Stem Cell Products When others promote results from their online surveys, they fail to mention the uncontrolled nature of their was spearheaded by BioInformatics LLC’s Vice broadcast email invitations. To provide you with the most President of Advisory Services Tamara Zemlo, valid and accurate results possible, the respondents to our Ph.D., MPH, who has been the lead analyst on surveys are members of our unique online panel—The over 80 syndicated market research reports. For Science Advisory Board—which consists of more than this study, Dr. Zemlo consulted with multiple 43,000 verified life science and biomedical professionals stem cell products vendors to optimize the Analyst Expertise who have agreed to take part in our surveys, focus groups relevance of this study with regards to the and other market research activities. These respondents current stem cell research market. are carefully selected based on their professional qualifications, market segments and geographic regions—we can even select them based on the products Sources of Independent, Unbiased Research they use and their preferred suppliers. Unlike reports from other firms that are based on an analyst’s subjective summary of information from publicly available sources, our reports are based on the results Don’t settle for an imitation. Invest in the most of detailed surveys of hundreds—even thousands—of direct source of information from the scientists scientific and medical professionals who buy your Company Information who buy your products, and the expert team that products. has been monitoring your clients since 1994. Developed by a Team of Experts Complimentary Consulting Provided Our questionnaires are developed by a multi- disciplinary team of scientists, industry veterans and With your purchase, we offer one free hour of consultation market research experts with years of experience. These with our talented team of scientific and business analysts professionals understand that survey questions need to who created the report. During this consultation, we can be asked in a way that ensures the answers will directly answer any questions you may have about the survey address the business challenges you face. Once the survey results and what we believe to be the significant trends data is collected, this same team creates a unique report affecting the market. that presents the reader with a thorough understanding of Custom Analysis & Research Available the topic and the scientific and business implications of Order Form the results based on sophisticated statistical analytics. If you’d like to delve deeper into the data from a study, we can always perform custom cross-tabulations or other analysis on your behalf. We can even pose follow-up questions to respondents who answered in a particular way or conduct a custom study to extend your knowledge. Capitalizing on New Opportunities for Stem Cell Products Executive Summary Page 5 of 7 ©2009 BioInformatics, LLC
  • 6. About BioInformatics, LLC Our strength lies in our ability to integrate our understanding of science and medicine with cutting-edge market research techniques. As one of the first firms to recognize how the World Wide Web has Since our inception in 1994, BioInformatics has provided critical transformed market research, BioInformatics formed The Science market intelligence to leading companies serving the life science, medical device and pharmaceutical industries. We support clients Advisory Board. Launched in 1997, this global community currently Overview across the entire market spectrum—from scientific research to consists of more than 43,000 life science researchers, physicians diagnostics and therapeutics—providing high-level management with and biomedical professionals who convene regularly via the Web to market insights from gene to drug. voice their opinions on a wide variety of issues relating to biomedical research and clinical technologies. Clients tap into this panel of Our multi-disciplinary team of scientific experts and business experts and receive answers to their critical marketing questions in analysts creates value for our clients by combining extensive industry days, rather than weeks. In addition to providing real-time insights knowledge and experience. We offer a variety of products and into the perceptions of the market, posing questions to The Science services that enable executives to see themselves, their market and Advisory Board offers substantial cost savings over gathering their competitors through the eyes of the most important information information via traditional market research techniques. source of all—customers. We can precisely meet the needs of our & Key Findings Methodology clients through the most appropriate mix of research methodologies, BioInformatics offers both published reports and custom research including: services. Published reports allow marketing professionals to share in • Online Surveys the results of broad-based market studies that provide access to high • Online Focus Groups quality research at an affordable price. Our custom research is tailored • Mail Surveys to the specific needs of the company’s executive management. For • Telephone Interviews more information about BioInformatics’ product and service offerings, please visit our Web site at www.gene2drug.com, call 703.778.3080 or email info@gene2drug.com. Our Valued Clients Report Highlights Biotechnology/Life Science Eppendorf Plexagen Diagnostics Ortho-Clinical Diagnostics Phillip Johnson & Associates 454 Eurogentec Post Genome Institute Radiometer America PA Consulting AbCam Expression Pathology Promega Tektronix Perry Ballard Accelrys Fermentas Protein Forest Piper Jaffray Pharmaceuticals Affymetrix Fluidigm Proteome Systems Ruder Finn Agencourt Bioscience GE Healthcare Qbiogene Abbott Laboratories Scherago International Agilent Technologies Gen-Probe QIAGEN Amgen Select Equity Group American Type Culture Gene Codes R & D Systems AstraZeneca Stephan & Brady Collection Gene Logic Ribomed Biotechnologies Aventis The Strategy Works Anachem Gene Therapy Systems Rosetta Biosoftware Baxter Healthcare UBS Warburg Antibodies By Design Gentra Systems Sachem Bayer Apple Computer Publishers & Associations GenVault Corporation Sarstedt Boehringer Ingelheim Applied Biosystems Pharmaceuticals Genzyme Sandia National Laboratories Academic Press Analyst Expertise Applied Precision Cardinal Health Guava Technologies SAS Institute American Academy of Axxora Centocor Pediatrics Helicos BioSciences Schott Nexterion BD Biosciences Hoechst Marion Roussel AAAS/Science Hewlett-Packard Sequenom Beckman Coulter ICN Pharmaceuticals American Medical Association High Throughput Genomics Serologicals Biacore Janssen Pharmaceutica American Society for Cell Hitachi Instruments Serotec Biology Bio-Rad Laboratories Merck Hybrigenics Sigma-Aldrich American Society for Bioneer Novartis Pharmaceuticals Hyseq Solexa Microbiology Biotage Novo Nordisk IBM Life Sciences SomaLogic American Society of Human Pharmaceuticals BioTrove Illumina Source Precision Medicine Genetics Pfizer Blue Heron Biotechnology Immunotech Stratagene BioTechniques/Eaton Schering-Plough Caliper Technologies InforMax Stressgen Biotechnologies Publishing Callida Genomics Integrated DNA Technologies Takara Mirus Bio Blackwell Publishing Company Information Professional Services Cambrex Bio Science Invitrogen Tecan Cold Spring Harbor & Finance Carl Zeiss JRH Biosciences The Jackson Laboratory Laboratory Press Adjuvant Partners Cell Signaling Technology Kirkegaard & Perry Thermo Fisher Scientific Elsevier Adventus Research Celliance Laboratories Thomas Scientific Federation of Amer. Societies Agency.com Charles River Laboratories Kodak Scientific Imaging Tocris Cookson for Experimental Biology Anvil Group ChromaVision Medical Leica Microsystems Transgenomic Harvard University Medical Atlas Venture Systems LI-COR UVP School Battelle Memorial Institute Cipher Systems LION bioscience Varian John Wiley & Sons BioOnline Clontech Laboratories Lonza VWR International Mary Ann Liebert Publishers Citadel Investment Group Corning Luminex Vysis Nature Publishing Group Doran Media Services DAKO MDS Sciex Waters New England Journal of Fidelity Management and DNAStar Mettler-Toledo AutoChem Whatman Medicine Research Dow Corning Millipore Society for Neuroscience Foley & Lardner Dynal Biotech MiraiBio Medical Diagnostics Springer-Verlag Gerson Lehrman Group eBIOINFORMATICS Molecular Devices Applied Imaging Stanford University High Wire HSBC Securities Edge Biosystems MWG Biotech Ciba Corning Diagnostics Order Form Press Infotrieve Eksigent Technologies New England Biolabs Dade Behring Thomson ISI Innovative Marketing Group EM Separations Technology NuGEN Technologies Diagnostic Products Wolters Kluwer McKinsey & Co. EMD Biosciences Ovid Technologies Diametrics Medical Nathan Associates Entelechon Pall Life Sciences Hewlett-Packard Medical National Research Council of Epigenomics Percival Scientific Products Canada Epitomics PerkinElmer Life Sciences LifeScan Novintel Epoch Biosciences Photometrics Mallinckrodt Capitalizing on New Opportunities for Stem Cell Products Executive Summary Page 6 of 7 ©2009 BioInformatics, LLC
  • 7. BioInformatics REPORT #09-002 market insights from gene to drug Capitalizing on New Opportunities for Stem Cell Products Overview PRE-PUBLICATION DISCOUNT PRICES are only available until May 17, 2009! Print Copy—$3,200 Now $2,700! Electronic Copy (includes one print copy)—$5,200 Now $4,500! Ordering Information Electronic Copy To place an order, fill out this form and mail it to BioInformatics, LLC or fax This format allows an unlimited number of users within your company it to 703.778.3081. Alternatively, you may submit your order by emailing to access the report regardless of geographic location. You may place the sales@gene2drug.com, calling 703.778.3080 or visiting electronic copy (PDF) on your secure, corporate intranet or share it with & Key Findings Methodology www.gene2drug.com/order/201/. co-workers via email. In addition to providing greater accessibility, the electronic copy allows you to easily navigate the document with the help Payment must be made within 30 days and in U.S. dollars. of bookmarks, quickly search key words or phrases and print out any page. BioInformatics’ Federal Tax ID #: 54-2001907. One print copy of the report is also provided at no additional cost. Credit Card Data Set You may charge your order to American Express, MasterCard, Visa, To accommodate your unique needs, the raw data is also available. With Diner’s Card or Discover. Please include your credit card account number, the data, you can analyze respondents’ answer choices in any way needed, expiration date and signature. including cross-tabulations, correlations, etc. The data set is offered in two formats: SPSS® Base or Microsoft® Excel, and may only be purchased in Wire Transfers conjunction with the company-wide electronic copy of the report. Wire transfers should be sent to: SunTrust Bank, 2121 15th Street, Arlington, Report Highlights VA 22201, SWIFT #SNTRUS3A, ABA #071000104, Account #702260169. I wish to order the following format of REPORT #09-002, Capitalizing on New Opportunities for Stem Cell Products Discount Price o Print Copy $2,700 $________ o Electronic Copy (.pdf, includes print copy) $4,500 $________ o Add Data Set Excel or SPSS (circle one) +$1,200 +$________ Additional print copies _____ x $300 each +$________ Analyst Expertise Promo Code ___________ –$________ Shipping & Handling +$________ (Add $15 for U.S., $50 for Int’l) $________ Total o Check Enclosed (Payable to BioInformatics, LLC) Company Information o Purchase Order # ________________________________________ Name o Bill Me Title o Am Ex o MasterCard o Visa o Diner’s Card o Discover Organization  / Street Address Credit Card # Exp Date (MM/YY) City, State/Province, Postal Code Name on card _____________________________________________ Country Order Authorized By: Order Form Phone Fax __________________________________________________________ Signature Date Email BioInformatics, LLC 2111 Wilson Blvd., Suite 250 Arlington, VA 22201 Web: www.gene2drug.com • Phone: 703.778.3080 x13 • Fax: 703.778.3081 • Email: m.follin@gene2drug.com Capitalizing on New Opportunities for Stem Cell Products Executive Summary Page 7 of 7 ©2009 BioInformatics, LLC